10/10/2016 5:13:42 PM
|written By : Team India Se|
In response to the growing threat of antibiotic resistance, the World Health Organization has issued new guidelines for the treatment of three common sexually transmitted infections (STIs).
Chlamydia, gonorrhoea and syphilis are all caused by bacteria and are generally curable with antibiotics. However, there is a problem. These STIs often go undiagnosed and are becoming more difficult to treat, with some antibiotics now failing as a result of misuse and overuse. It is estimated that, each year, 131 million people are infected with chlamydia, 78 million with gonorrhoea, and 5.6 million with syphilis.
Resistance of these STIs to the effect of antibiotics has increased rapidly in recent years and has reduced treatment options. Of the three STIs, gonorrhoea has developed the strongest resistance to antibiotics. Antibiotic resistance in chlamydia and syphilis, though less common, also exists, making prevention and prompt treatment critical.
When left undiagnosed and untreated, these STIs can result in serious complications and long-term health problems for women.
“Chlamydia, gonorrhoea and syphilis are major public health problems worldwide, affecting millions of people’s quality of life, causing serious illness and sometimes death. The new WHO guidelines reinforce the need to treat these STIs with the right antibiotic, at the right dose, and the right time to reduce their spread and improve sexual and reproductive health. To do that, national health services need to monitor the patterns of antibiotic resistance in these infections within their countries,” said Ian Askew, Director of Reproductive Health and Research, WHO.